10.13.20

J&J Pauses COVID-19 Vaccine Studies After “Unexplained Illness”

Source: FirstWord

09.28.20

J&J’s COVID-19 Vaccine “Highly Immunogenic” in Early-Stage Testing

Source: FirstWord

09.23.20

Johnson & Johnson Starts Phase 3 Study of COVID-19 Vaccine Candidate

Source: Bloomberg

08.21.20

J&J Looking to Enroll 60,000 Participants in Coronavirus Vaccine Trial

Source: FirstWord

08.19.20

Johnson & Johnson to Buy Momenta for $6.5 billion

Source: FirstWord

08.18.20

Why Johnson & Johnson is Investing in This Niche Telehealth Startup

Source: FierceHealthcare

08.14.20

EU Wraps Up Exploratory Talks With J&J to Secure Coronavirus Vaccine

Source: FirstWord

08.06.20

Johnson & Johnson Forges $1-Billion Pact to Supply US with COVID-19 Vaccine

Source: FirstWord

07.30.20

J&J Vaccine Protects Monkeys From Covid With Single Shot

Source: Bloomberg

07.17.20

J&J Eyes Late-Stage Study Start of COVID-19 Vaccine in September

Source: FirstWord

View more stories